{"id":686192,"date":"2026-04-08T03:16:03","date_gmt":"2026-04-08T03:16:03","guid":{"rendered":"https:\/\/microscopemedia.com\/?p=686192"},"modified":"2026-04-08T03:16:03","modified_gmt":"2026-04-08T03:16:03","slug":"noi-medicamente-tintesc-una-dintre-cele-mai-periculoase-mutatii-din-cancer","status":"publish","type":"post","link":"https:\/\/microscopemedia.com\/?p=686192","title":{"rendered":"Noi medicamente \u021bintesc una dintre cele mai periculoase muta\u021bii din cancer"},"content":{"rendered":"<div><img decoding=\"async\" src=\"https:\/\/microscopemedia.com\/wp-content\/uploads\/2026\/04\/noi-medicamente-tintesc-una-dintre-cele-mai-periculoase-mutatii-din-cancer.jpg\" class=\"ff-og-image-inserted\"><\/div>\n<p id=\"p-0\">Considerat\u0103 mult timp \u201eimposibil de tratat\u201d, proteina KRAS \u00eencepe acum s\u0103 fie abordat\u0103 cu succes prin tehnologii moderne \u0219i strategii inovatoare.<\/p>\n<p id=\"p-1\">KRAS face parte din familia proteinelor RAS, esen\u021biale pentru cre\u0219terea \u0219i diviziunea celular\u0103.<\/p>\n<p id=\"p-2\">\u00cen anumite muta\u021bii, proteina r\u0103m\u00e2ne blocat\u0103 \u00eentr-o stare activ\u0103, determin\u00e2nd proliferarea necontrolat\u0103 a celulelor \u2013 un mecanism central \u00een dezvoltarea cancerului.<\/p>\n<h2 id=\"chapter-0\">Prime rezultate promi\u021b\u0103toare \u00een studii clinice<\/h2>\n<p id=\"p-3\">Un progres major vine din testarea unei noi clase de medicamente, numite \u201edegradatori\u201d, care nu doar inhib\u0103 proteina KRAS, ci o elimin\u0103 complet din celule.<\/p>\n<p id=\"p-4\">Acestea marcheaz\u0103 proteina ca \u201ede\u0219eu celular\u201d, determin\u00e2nd distrugerea ei de c\u0103tre mecanismele interne ale celulei.<\/p>\n<p id=\"p-5\">Un astfel de medicament \u2013 Setidegrasib \u2013 a ar\u0103tat rezultate \u00eencurajatoare \u00een primul studiu clinic pe oameni, publicat \u00een <a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2600752\" target=\"_blank\" rel=\"noopener\">The New England Journal of Medicine<\/a>. Tumorile s-au redus la peste o treime dintre pacien\u021bii cu cancer pulmonar \u0219i la aproximativ un sfert dintre cei cu cancer pancreatic.<\/p>\n<p id=\"p-6\">Totu\u0219i, speciali\u0219tii avertizeaz\u0103 c\u0103 efectele nu sunt \u00eenc\u0103 de durat\u0103, iar rezisten\u021ba la tratament r\u0103m\u00e2ne o provocare.<\/p>\n<h2 id=\"chapter-1\">Combina\u021biile de terapii, cheia viitorului<\/h2>\n<p id=\"p-7\">O alt\u0103 direc\u021bie promi\u021b\u0103toare o reprezint\u0103 medicamentele care blocheaz\u0103 mai multe forme ale proteinei KRAS \u0219i ale rudelor sale. Un exemplu este Daraxonrasib, aflat \u00een studii clinice avansate, ale c\u0103rui rezultate sunt a\u0219teptate \u00een cur\u00e2nd, potrivit revistei Nature.<\/p>\n<p id=\"p-8\">Cercet\u0103torii cred c\u0103 viitorul tratamentelor nu va consta \u00eentr-un singur medicament, ci \u00een combina\u021bii de terapii.<\/p>\n<p id=\"p-9\">Studiile preliminare sugereaz\u0103 c\u0103 asocierea mai multor inhibitori KRAS poate produce efecte mult mai puternice dec\u00e2t utilizarea lor separat\u0103.<\/p>\n<h2 id=\"chapter-2\">De la imposibil la posibil<\/h2>\n<p id=\"p-10\">De\u0219i niciuna dintre aceste abord\u0103ri nu ofer\u0103 \u00eenc\u0103 un tratament definitiv, schimbarea de paradigm\u0103 este semnificativ\u0103.<\/p>\n<p id=\"p-11\">Dup\u0103 decenii de e\u0219ecuri, domeniul cunoa\u0219te o accelerare rapid\u0103, iar speciali\u0219tii vorbesc despre o nou\u0103 er\u0103 \u00een lupta \u00eempotriva cancerelor determinate de muta\u021biile KRAS.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Considerat\u0103 mult timp \u201eimposibil de tratat\u201d, proteina KRAS \u00eencepe acum s\u0103 fie abordat\u0103 cu succes prin tehnologii moderne \u0219i strategii inovatoare. KRAS face parte din familia proteinelor RAS, esen\u021biale pentru &hellip; <a href=\"https:\/\/microscopemedia.com\/?p=686192\" class=\"more-link\">Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":686193,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/686192"}],"collection":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=686192"}],"version-history":[{"count":0,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/686192\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/media\/686193"}],"wp:attachment":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=686192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=686192"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=686192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}